CAPR News & Analysis
2 articles
Market Mood
Kaos Capital Proposes Board Changes at Capricor Therapeutics
Kaos Capital has initiated steps to propose changes to the board at Capricor Therapeutics. This move is part of a broader effort to influence the company's strategic direction. While no specific figures or quantitative data were mentioned, the push for board changes signals a potential shift in governance that could affect shareholder interests. For investors, this could lead to changes in the company's operational decisions and overall market performance.
Read More: Kaos Capital Proposes Board Changes at Capricor Therapeutics
Capricor Therapeutics (CAPR) Files Form 144 on May 19
Capricor Therapeutics (CAPR) submitted Form 144 on May 19, indicating the intention to sell shares for a specified amount. This filing is a regulatory requirement for sellers of restricted securities. The document helps investors understand potential selling pressure on the stock. Such transactions may impact trading volumes and share price.
Read More: Capricor Therapeutics (CAPR) Files Form 144 on May 19